Company Monitoring Page for Vivus

latest headlines for company on cafepharma

Arena's Obese To-Do List
Motley Fool
Sat, 01/29/11 - 11:32 am
Tags:
Arena Pharmaceuticals, Qnexa, Vivus
Rats Plague Arena's Diet Pill
Minyanville
Sat, 01/29/11 - 11:20 am
Tags:
Arena Pharmaceuticals, Orexigen, obesity, diet drugs, Qnexa, Vivus
Biotech Stock Mailbag: Orexigen Therapeutics
TheStreet.com
Fri, 01/28/11 - 12:13 pm
Tags:
Orexigen, Contrave, Arena Pharmaceuticals, Vivus, Avanir, Discovery Labs, Cel-Sci
Vivus says FDA asks about Qnexa birth defect link
Yahoo/AP
Fri, 01/21/11 - 10:10 am
Tags:
Qnexa, birth defects, FDA, Vivus, obesity
Smart Money's 9 Top Biotech Stock Picks
Seeking Alpha
Mon, 01/17/11 - 12:53 pm
Tags:
biotech, Cadence Pharmaceuticals, Cell Therapeutics, Enzon, Geron, Exelixis, Seattle Genetics, Savient, Vivus, Theravance
Vivus Says Erection Drug Works in 80 Percent of Men
Bloomberg
Thu, 01/13/11 - 01:35 pm
Tags:
Vivus, erectile dysfunction, Avanafil
2011 Drugmaker M&A Targets
Motley Fool
Fri, 12/31/10 - 10:00 am
Tags:
M&A, Pfizer, Merck, Genzyme, Sanofi, JNJ, Crucell, ONYX Pharmaceuticals, Bayer, Momenta, Novartis, GSK, Human Genome Sciences, Vertex Pharmaceuticals, MannKind, Vivus, Savient
Vivus applies to market obesity drug Qnexa in EU
Marketwatch
Mon, 12/20/10 - 12:31 pm
Tags:
Vivus, Qnexa, obesity, EU, Europe
ED Drug Could Support Vivus
Yahoo/Zacks.com
Thu, 12/9/10 - 12:22 pm
Tags:
erectile dysfunction, Vivus, Pfizer, GSK, Avanafil
Diet Drug Rally: Orexigen, Vivus, Arena
TheStreet.com
Wed, 12/8/10 - 12:27 pm
Tags:
obesity, Orexigen, Vivus, Arena Pharmaceuticals, Contrave, Qnexa
Orexigen: Don't Count Contrave Out Yet
Seeking Alpha
Fri, 12/3/10 - 06:45 am
Tags:
FDA, obesity, Orexigen, Contrave, Arena Pharmaceuticals, Vivus
Orexigen Options Suggest Contrave Diet Pill May Avoid Arena, Vivus Delays
Bloomberg
Thu, 12/2/10 - 10:17 am
Tags:
Orexigen, options, Contrave, obesity, Vivus, Arena Pharmaceuticals
Orexigen: Contrave FDA Panel Preview
TheStreet.com
Tue, 11/30/10 - 08:02 am
Tags:
FDA, advisory panels, Orexigen, Contrave, obesity, Arena Pharmaceuticals, Vivus
Vivus narrows Q3 loss to $18M
Bizjournals.com
Mon, 11/8/10 - 05:24 pm
Tags:
earnings, Vivus
Vivus sells Muse assets for $23.5M
Bizjournals.com
Mon, 11/8/10 - 10:51 am
Tags:
M&A, Muse, Vivus, Meda, erectile dysfunction
FDA Ends October With Drug Approvals, Rejection
TheStreet.com
Mon, 11/1/10 - 08:59 am
Tags:
FDA, Biodel, Avanir, Forest Labs, Arena Pharmaceuticals, Vivus, Amylin, Questcor Pharmaceuticals, Alkermes
Diet Drug Optimism Lifts Shares of Vivus
NY Times
Sat, 10/30/10 - 12:14 pm
Tags:
Vivus, Qnexa, obesity
Vivus Gains on Potential to Win U.S. Clearance for Obesity Drug Next Year
Bloomberg
Fri, 10/29/10 - 11:49 am
Tags:
Qnexa, FDA, obesity, Vivus
Whither Diet Pills? Why The FDA Keeps Saying No
Pharmalot
Fri, 10/29/10 - 11:45 am
Tags:
Vivus, Qnexa, obesity, diet pills, Arena Pharmaceuticals, FDA
Vivus Fails to Win U.S. Approval for Diet Pill Qnexa on Safety Concerns
Bloomberg
Thu, 10/28/10 - 10:17 pm
Tags:
FDA, diet drugs, Qnexa, Vivus, obesity

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.